REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 174 filers reported holding REATA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $41,515,053 | +161.4% | 407,170 | +133.1% | 0.21% | +149.4% |
| Q1 2023 | $15,883,815 | -72.3% | 174,701 | -88.4% | 0.08% | -72.7% |
| Q4 2022 | $57,342,258 | +272.9% | 1,509,404 | +146.7% | 0.31% | +298.7% |
| Q3 2022 | $15,378,000 | +1450.2% | 611,923 | +7522.4% | 0.08% | +2500.0% |
| Q4 2020 | $992,000 | +24.0% | 8,028 | -2.2% | 0.00% | +50.0% |
| Q3 2020 | $800,000 | -69.1% | 8,209 | -50.5% | 0.00% | -77.8% |
| Q2 2020 | $2,587,000 | -34.8% | 16,584 | -39.7% | 0.01% | 0.0% |
| Q1 2020 | $3,968,000 | +128.3% | 27,484 | +223.3% | 0.01% | +50.0% |
| Q4 2019 | $1,738,000 | +621.2% | 8,500 | +183.3% | 0.01% | +500.0% |
| Q3 2019 | $241,000 | +43.5% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $168,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |